2m 2m 2m 2m 2m 2m 2m
ACRIVON THERAPE (ACRV)
NASDAQ
$1.53+$0.02 (+1.67%)
Price as of Aug 03, 2026 11:32 AM EDT- $64.2MMarket Cap
- 19.05%1-Year Change
- BiotechnologyIndustry
ACRIVON THERAPE (ACRV)
$1.53+$0.02 (+1.67%)
ACRV | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.50 | ||
Change | -$0.02 (-1.32%) | ||
Open | $1.57 | ||
High | $1.64 | ||
Low | $1.50 | ||
Previous Close | $1.52 | ||
Volume | 506,280 | ||
30-Day Average Volume | 464,241 | ||
1-Week Change | -6.25% | ||
1-Month Change | -15.73% | ||
1-Year Change | 19.05% | ||
3-Year Change | -87.94% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 42.8M | ||
Total Assets | $107.8M | ||
Market Cap | $64.2M | ||
Enterprise Value | $30.1M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$19.0M | ||
Free Cash Flow | -$20.6M | ||
EBIT | -$19.0M | ||
EBITDA | -$18.7M | ||
Net Working Capital | $88.2M | ||
EPS | -$0.49 | ||
Enterprise Value/EBITDA | -2 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -3 | ||
PEG | -14 | ||
Price/Free Cash Flow | -3 | ||
Price/Operating Cash Flow | -3 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue